Boston, Massachusetts, USA — Tomocube, Inc., a leader in label-free 3D live cell imaging and AI-driven analysis, is excited to announce its participation in the ASCB|EMBO Meeting CELL BIO 2023. This premier event is scheduled from December 2 to December 6 at the Boston Convention and Exhibition Center. 

At booth #329, Tomocube, Inc. will introduce two groundbreaking innovations: the HT-X1 Holotomography Imaging System and the TomoAnalysis software suite. These cutting-edge solutions promise to revolutionize cell biology research by providing powerful tools for visualizing and analyzing cellular structures and dynamics. 

"We invite all attendees to visit booth #329 and experience the transformative potential of our HT-X1 Holotomography Imaging System and TomoAnalysis software," said Sumin Lee, Ph.D, VP of Customer Development at Tomocube, Inc. "These innovations open new frontiers in cell biology research, enabling researchers to explore the intricacies of cellular structures and dynamics.

Product Highlights: 

HT-X1 Holotomography Imaging System: The HT-X1 is a revolutionary low-coherence holotomography imaging system that enables researchers to visualize transparent specimens in three dimensions. By generating 3D refractive index (RI) tomograms, the HT-X1 represents valuable quantitative information about cells, including volume, area, protein and lipid concentration, and dry mass. This label-free approach provides a non-invasive means of investigating cellular structures and dynamics. 

The HT-X1 has outstanding performance in the key applications of quantitative phase imaging: 

  • Confluent & sensitive live cells: primary cells including stem cells, iPSC, neuronal cells, etc. 
  • Monitoring of multiple samples in a multi-well imaging plate up to 96 well with stable incubation system. 
  • Observing thicker samples: organoid, tissue, microfluidic device. 
  • Nanomaterial delivery: better resolution without speckle noise. 

TomoAnalysis Software: Discover TomoAnalysis, the ultimate software solution for refining, segmenting, quantifying, and analyzing for Holotomography. The highlighted functions of TomoAnalysis are lipid droplet quantification, cell instance segmentation, and fluorescence-based analysis. These functions use a refractive index (RI) based thresholding method to segment masks because Holotomography image represents RI distribution. The software automatically provides quantitative information of segmented features using the characteristics of RI which is linearly proportional to concentration of biomolecules. Users can use the fluorescence signal as supplementary data using corelative fluorescence imaging with Holotomography. The software offers core Analysis pipelines and provides a range of customizable features to address diverse user needs. Researchers can refine their image data, extract meaningful measurements, and conduct in-depth quantitative analyses. 

About Tomocube, Inc.: Tomocube, Inc. is a leading company at the forefront of label-free 3D live cell imaging and AI-enabled analysis. Our mission is to advance scientific discovery by offering state-of-the-art solutions for visualizing and studying the intricate world of cells. With a commitment to innovation and excellence, Tomocube, Inc. empowers researchers and scientists to make groundbreaking contributions to the field of cell biology. 

Don't miss this opportunity to witness the future of 3D live cell imaging at ASCB|EMBO Meeting CELL BIO 2023. For more information about Tomocube, Inc. and its cutting-edge products, please visit our website at www.tomocube.com

Contact: Sumin Lee, Ph.D. VP of Customer Development, Tomocube, Inc. slee@tomocube.com